That may be the case but I will say that the overwhelming majority fail due to safety/toxicity concerns, no such issues here. The other thing the company has in its favour is the fact that BIT225 has already been through plenty of clinical trials with a great deal of success.
With regards to the COVID trials, the mouse model used is the widely accepted COVID test model which greatly emulates the effect that COVID has on humans and the results were spectacular - it still may not necessarily work in humans I know but the signs are encouraging.
Anyway, each to their own, I'm willing to ride this to the end, I think the odds of success are better then 50/50...
$30 Billion Deal, page-3391
-
- There are more pages in this discussion • 1,689 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |